United States Amyloidosis Treatment Market Set for Breakthrough Growth with Innovative Therapies Driving Global Demand 2025 | Major key players - Merck & Co., Pfizer Inc., AstraZeneca plc.

Market Overview:

The Global Amyloidosis Treatment Market is estimated to reach at a Significant CAGR during the forecast period 2024-2031.

The Amyloidosis Treatment Market report, published by DataM Intelligence, provides in-depth insights and analysis on key market trends, growth opportunities, and emerging challenges. Committed to delivering actionable intelligence, DataM Intelligence empowers businesses to make informed decisions and stay ahead of the competition. Through a combination of qualitative and quantitative research methods, it offers comprehensive reports that help clients navigate complex market landscapes, drive strategic growth, and seize new opportunities in an ever-evolving global market.

Get a Free Sample PDF Of This Report (Get Higher Priority for Corporate Email ID): https://datamintelligence.com/download-sample/amyloidosis-treatment-market?sz

The Amyloidosis Treatment Market encompasses therapies, drugs, and interventions designed to manage and treat amyloidosis, a rare condition characterized by abnormal protein deposits in organs and tissues. It includes conventional and novel treatments, such as chemotherapy, targeted therapies, and supportive care, aiming to reduce amyloid accumulation, improve organ function, and enhance patient quality of life while addressing disease progression and symptoms.

Industry Recent Developments:

United States:

✅ January 2025: New reimbursement codes for amyloidosis therapy were introduced by CMS, leading to increased hospital investment in specialized amyloidosis treatment centers and expanded clinical study access.

✅ February 2025: The U.S. Department of Veterans Affairs (VA) expanded remote home-based amyloidosis management programs and remote monitoring, improving patient outcomes and lowering hospital readmissions.

✅ October 2025: Growth in the market is fueled by increased research collaborations, clinical trials, and awareness efforts alongside challenges of high treatment costs and limited approved drugs.

Japan:

✅ October 2025: The transthyretin amyloidosis treatment market in Japan is expected to grow at a CAGR of 12.3% from 2025 to 2030, with targeted therapies being the largest revenue-generating segment. (October 2025)

✅ The amyloidosis treatment market in Japan is projected to grow steadily with increasing investments in early diagnosis and treatment access for amyloidosis, supported by improved healthcare infrastructure and rising disposable incomes. (Recent, 2025)

✅ Japan accounted for 2.4% of the global transthyretin amyloidosis treatment market revenue in 2024 and is expected to increase its market share through expanded clinical programs and new therapeutic options. (2025 projections)

Speak to Our Analyst and Get Customization in the report as per your requirements: https://datamintelligence.com/customize/amyloidosis-treatment-market?sz

Major Key Players:

Merck & Co.
Pfizer Inc.
AstraZeneca plc.
Prothena Corporation plc.
Ionis Pharmaceuticals, Inc.
Bellus Health Inc.
Alnylam Pharmaceuticals, Inc
Eidos Therapeutics, Inc
Corino Therapeutics, Inc.
Spectrum Pharmaceuticals, Inc.

Key Growth Drivers:

Rising prevalence of transthyretin amyloidosis (ATTR) and increased diagnostic rates due to advancements in genetic testing, biomarker-based diagnostics, and awareness campaigns, which expand the patient base eligible for treatment.

Growing patient preference for novel, disease-modifying therapies that target the underlying pathology of amyloidosis, including RNA interference (RNAi) therapies and transthyretin (TTR) stabilizers that delay disease progression.

Increased awareness and early diagnosis initiatives supported by advancements in diagnostic capabilities such as cardiac MRI, bone scintigraphy, and genetic testing, enabling faster detection and timely treatment initiation.

Segments Covered in the Amyloidosis Treatment Market:

By Type: Light-chain (AL) amyloidosis, AA amyloidosis, Transthyretin amyloidosis (ATTR), Dialysis-Related Amyloidosis, Others.

By Treatment: Chemotherapy, Supportive care, Surgery, Stem Cell Transplant, Targeted Therapy Others.

By Drugs: Transthyretin Transport Inhibitor, Immunomodulatory Drugs, Monoclonal Antibodies, Proteasome Inhibitors, Others.

By Distribution Channel: Hospitals Pharmacies, Retail Pharmacies, Online pharmacies, Others.

Regional Analysis:

⇥ North America (U.S., Canada, Mexico)

⇥ Europe (U.K., Italy, Germany, Russia, France, Spain, The Netherlands and Rest of Europe)

⇥ Asia-Pacific (India, Japan, China, South Korea, Australia, Indonesia Rest of Asia Pacific)

⇥ South America (Colombia, Brazil, Argentina, Rest of South America)

⇥ Middle East & Africa (Saudi Arabia, U.A.E., South Africa, Rest of Middle East & Africa)

Looking For Full Report? Get it Here: https://www.datamintelligence.com/buy-now-page?report=amyloidosis-treatment-market

Chapter Outline

⏩ Market Overview: It contains five chapters, as well as information about the research scope, major manufacturers covered, market segments, Amyloidosis Treatment market segments, study objectives, and years considered.

⏩ Market Landscape: The competition in the Global Amyloidosis Treatment Market is evaluated here in terms of value, turnover, revenues, and market share by organization, as well as market rate, competitive landscape, and recent developments, transaction, growth, sale, and market shares of top companies.

⏩ Companies Profiles: The Global Amyloidosis Treatment market's leading players are studied based on sales, main products, gross profit margin, revenue, price, and growth production.

⏩ Market Outlook by Region: The report goes through gross margin, sales, income, supply, market share, CAGR, and market size by region in this segment. North America, Europe, Asia Pacific, Middle East & Africa, and South America are among the regions and countries studied in depth in this study.

⏩ Market Segments: It contains the deep research study which interprets how different end-user/application/type segments contribute to the Amyloidosis Treatment Market.

⏩ Market Forecast: Production Side: In this part of the report, the authors have focused on production and production value forecast, key producers forecast, and production and production value forecast by type.

⏩ Research Findings: This section of the report showcases the findings and analysis of the report.

⏩ Conclusion: This portion of the report is the last section of the report where the conclusion of the research study is provided.

Unlock 360° Market Intelligence with DataM Subscription Services: https://www.datamintelligence.com/reports-subscription

People Also Ask:

◆ How big is the Amyloidosis Treatment Market in 2025?
◆ What is the projected growth rate of the Amyloidosis Treatment Market through 2033?
◆ Who are the key players in the Amyloidosis Treatment Market?
◆ Which region is expected to dominate the industry during the forecast period?

Contact Us -
Company Name: DataM Intelligence
Contact Person: Sai Kiran
Email: Sai.k@datamintelligence.com
Phone: +1 877 441 4866
Website: https://www.datamintelligence.com

About Us -
DataM Intelligence is a Market Research and Consulting firm that provides end-to-end business solutions to organizations from Research to Consulting. We, at DataM Intelligence, leverage our top trademark trends, insights and developments to emancipate swift and astute solutions to clients like you. We encompass a multitude of syndicate reports and customized reports with a robust methodology.
Our research database features countless statistics and in-depth analyses across a wide range of 6300+ reports in 40+ domains creating business solutions for more than 200+ companies across 50+ countries; catering to the key business research needs that influence the growth trajectory of our vast clientele.

This release was published on openPR.